Back
Structure Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
GPCR
Structure Therapeutics, Inc.
Last Price:
$71.92
Seasonality Move:
-11.15%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and GPCR is experiencing slight selling pressure.
Structure Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.56 | Sell |
| 20-day SMA: | 85.26 | Sell |
| 50-day SMA: | 70.91 | Buy |
| 200-day SMA: | 35.83 | Buy |
| 8-day EMA: | 79.35 | Sell |
| 20-day EMA: | 80.22 | Sell |
| 50-day EMA: | 70.64 | Buy |
| 200-day EMA: | 44.69 | Buy |
Structure Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.69 | Buy |
| Relative Strength Index (14 RSI): | 46.3 | Sell |
| Chaikin Money Flow: | -129117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.79 - 90.55) | Sell |
| Bollinger Bands (100): | (27.26 - 74) | Buy |
Structure Therapeutics, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics, Inc. Stock
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 75.98 while GPCR 8-day simple moving average is 79.56, which is a Sell signal.
-
The stock price of GPCR is 75.98 while Structure Therapeutics, Inc. 20-day SMA is 85.26, which makes it a Sell.
-
Structure Therapeutics, Inc. 50-day simple moving average is 70.91 while GPCR share price is 75.98, making it a Buy technically.
-
GPCR stock price is 75.98 and Structure Therapeutics, Inc. 200-day simple moving average is 35.83, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
50
Structure Therapeutics, Inc. (GPCR)
is a Sell
Is Structure Therapeutics, Inc. a Buy or a Sell?
-
Structure Therapeutics, Inc. stock is rated a SellThe current Structure Therapeutics, Inc. [GPCR] share price is $75.98. The Score for GPCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics, Inc. Stock Info
Market Cap:
4.4B
Price in USD:
75.98
Share Volume:
415.3K
Structure Therapeutics, Inc. 52-Week Range
52-Week High:
94.90
52-Week Low:
13.22
Sell
50
Structure Therapeutics, Inc. (GPCR)
is a Sell
Structure Therapeutics, Inc. Share Price Forecast
-
What is the Structure Therapeutics, Inc. stock price today?The Structure Therapeutics, Inc. stock price is 75.98 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics, Inc. is overvalued.
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 75.98 while GPCR 8-day exponential moving average is 79.35, which is a Sell signal.
-
The stock price of GPCR is 75.98 while Structure Therapeutics, Inc. 20-day EMA is 80.22, which makes it a Sell.
-
Structure Therapeutics, Inc. 50-day exponential moving average is 70.64 while GPCR share price is 75.98, making it a Buy technically.
-
GPCR stock price is 75.98 and Structure Therapeutics, Inc. 200-day simple moving average is 44.69, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics, Inc.
Is Structure Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Structure Therapeutics, Inc.
Should I short Structure Therapeutics, Inc. stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 1.69, suggesting Structure Therapeutics, Inc. is a Buy
-
Structure Therapeutics, Inc. Relative Strength Index (RSI) is 46.3, which suggest Structure Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Structure Therapeutics, Inc. is (73.79 - 90.55), which suggest Structure Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Structure Therapeutics, Inc. is (27.26 - 74), which suggest Structure Therapeutics, Inc. is a Buy
* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.